Taken together, our findings indicate that the PD-L1 expression on VECs can realistically inhibit the immune-activation in microenvironment through promoting the aggregation of FoxP3+ T cells and inhibiting the function and infiltration of CD8+ T cells in tumor. This evidence concerns the gene FOXP3 and neoplasm.